☰

James Chester Dabrowiak - Publications

Affiliations: 
1972- Chemistry Syracuse University, Syracuse, NY, United States 
Area:
Bioinorganic chemistry; metallo-pharmaceutical chemistry
Website:
https://thecollege.syr.edu/people/faculty/dabrowiak-james/
Tree Info Similar researchers PubMed Report error

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Alexander CM, Hamner KL, Maye MM, Dabrowiak JC. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery. Bioconjugate Chemistry. 25: 1261-71. PMID 24911830 DOI: 10.1021/Bc500136R  0.718
2013 Shi Y, Goodisman J, Dabrowiak JC. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin. Inorganic Chemistry. 52: 9418-26. PMID 23889547 DOI: 10.1021/Ic400989V  0.457
2013 Alexander CM, Dabrowiak JC, Goodisman J. Gravitational sedimentation of gold nanoparticles. Journal of Colloid and Interface Science. 396: 53-62. PMID 23403117 DOI: 10.1016/J.Jcis.2013.01.005  0.534
2012 Alexander CM, Dabrowiak JC, Maye MM. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D. Bioconjugate Chemistry. 23: 2061-70. PMID 23043330 DOI: 10.1021/Bc3002634  0.731
2012 Hasenoehrl C, Alexander CM, Azzarelli NN, Dabrowiak JC. Enhanced detection of gold nanoparticles in agarose gel electrophoresis. Electrophoresis. 33: 1251-4. PMID 22589102 DOI: 10.1002/Elps.201100556  0.54
2012 Shi Y, Liu SA, Kerwood DJ, Goodisman J, Dabrowiak JC. Pt(IV) complexes as prodrugs for cisplatin. Journal of Inorganic Biochemistry. 107: 6-14. PMID 22169035 DOI: 10.1016/J.Jinorgbio.2011.10.012  0.507
2012 Shi Y, Dabrowiak JC. Host -guest interactions involving platinum anticancer agents. DNA binding and cytotoxicity of a β-cyclodextrin-adamantane-Pt(IV) complex Inorganica Chimica Acta. 393: 337-339. DOI: 10.1016/J.Ica.2012.06.021  0.458
2012 Di Pasqua AJ, Goodisman J, Dabrowiak JC. Understanding how the platinum anticancer drug carboplatin works: From the bottle to the cell Inorganica Chimica Acta. 389: 29-35. DOI: 10.1016/J.Ica.2012.01.028  0.366
2011 Prashar D, Shi Y, Bandyopadhyay D, Dabrowiak JC, Luk YY. Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification. Bioorganic & Medicinal Chemistry Letters. 21: 7421-5. PMID 22050886 DOI: 10.1016/J.Bmcl.2011.10.006  0.447
2011 Di Pasqua AJ, Kerwood DJ, Shi Y, Goodisman J, Dabrowiak JC. Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association. Dalton Transactions (Cambridge, England : 2003). 40: 4821-5. PMID 21461444 DOI: 10.1039/C0Dt01758B  0.734
2011 Alexander CM, Maye MM, Dabrowiak JC. DNA-capped nanoparticles designed for doxorubicin drug delivery. Chemical Communications (Cambridge, England). 47: 3418-20. PMID 21286626 DOI: 10.1039/C0Cc04916F  0.722
2010 Shi Y, Toms BB, Dixit N, Kumari N, Mishra L, Goodisman J, Dabrowiak JC. Cytotoxicity of Cu(II) and Zn(II) 2,2'-bipyridyl complexes: dependence of IC50 on recovery time. Chemical Research in Toxicology. 23: 1417-26. PMID 20672868 DOI: 10.1021/Tx100126F  0.454
2009 Di Pasqua AJ, Wallner S, Kerwood DJ, Dabrowiak JC. Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica. Chemistry & Biodiversity. 6: 1343-9. PMID 19774597 DOI: 10.1002/Cbdv.200900021  0.706
2009 Di Pasqua AJ, Centerwall CR, Kerwood DJ, Dabrowiak JC. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate. Inorganic Chemistry. 48: 1192-7. PMID 19113934 DOI: 10.1021/Ic801579H  0.704
2008 Sorokanich RS, Di Pasqua AJ, Geier M, Dabrowiak JC. Influence of carbonate on the binding of carboplatin to DNA. Chemistry & Biodiversity. 5: 1540-4. PMID 18729090 DOI: 10.1002/Cbdv.200890142  0.736
2008 Centerwall CR, Kerwood DJ, Goodisman J, Toms BB, Dabrowiak JC. New extracellular resistance mechanism for cisplatin. Journal of Inorganic Biochemistry. 102: 1044-9. PMID 18294693 DOI: 10.1016/J.Jinorgbio.2008.01.008  0.322
2008 Di Pasqua AJ, Sharma KK, Shi YL, Toms BB, Ouellette W, Dabrowiak JC, Asefa T. Cytotoxicity of mesoporous silica nanomaterials. Journal of Inorganic Biochemistry. 102: 1416-23. PMID 18279965 DOI: 10.1016/J.Jinorgbio.2007.12.028  0.697
2007 Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dabrowiak JC. Modification of carboplatin by Jurkat cells. Journal of Inorganic Biochemistry. 101: 1438-41. PMID 17655933 DOI: 10.1016/J.Jinorgbio.2007.06.018  0.71
2007 Ravera M, Bagni G, Mascini M, Dabrowiak JC, Osella D. The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor. Journal of Inorganic Biochemistry. 101: 1023-7. PMID 17524484 DOI: 10.1016/J.Jinorgbio.2007.03.017  0.404
2007 Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC. Role of carbonate in the cytotoxicity of carboplatin. Chemical Research in Toxicology. 20: 896-904. PMID 17497898 DOI: 10.1021/Tx700058F  0.71
2006 Centerwall CR, Tacka KA, Kerwood DJ, Goodisman J, Toms BB, Dubowy RL, Dabrowiak JC. Modification and uptake of a cisplatin carbonato complex by Jurkat cells. Molecular Pharmacology. 70: 348-55. PMID 16632646 DOI: 10.1124/Mol.106.023184  0.778
2006 Binter A, Goodisman J, Dabrowiak JC. Formation of monofunctional cisplatin-DNA adducts in carbonate buffer. Journal of Inorganic Biochemistry. 100: 1219-24. PMID 16545458 DOI: 10.1016/J.Jinorgbio.2006.01.040  0.419
2006 Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC. Activation of carboplatin by carbonate. Chemical Research in Toxicology. 19: 139-49. PMID 16411667 DOI: 10.1021/Tx050261S  0.698
2004 Tacka KA, Szalda D, Souid AK, Goodisman J, Dabrowiak JC. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells. Chemical Research in Toxicology. 17: 1434-44. PMID 15540941 DOI: 10.1021/Tx0498760  0.803
2004 Tacka KA, Dabrowiak JC, Goodisman J, Penefsky HS, Souid AK. Effects of cisplatin on mitochondrial function in Jurkat cells. Chemical Research in Toxicology. 17: 1102-11. PMID 15310242 DOI: 10.1021/Tx0499564  0.788
2004 McPike MP, Goodisman J, Dabrowiak JC. Specificity of neomycin analogues bound to the packaging region of human immunodeficiency virus type 1 RNA. Bioorganic & Medicinal Chemistry. 12: 1835-43. PMID 15051052 DOI: 10.1016/J.Bmc.2004.01.044  0.772
2004 Tacka KA, Dabrowiak JC, Goodisman J, Penefsky HS, Souid A. Effects of Cisplatin on Mitochondrial Function in Jurkat Cells Volume 17, Number 8, August 2004, pp 1102−1111 Chemical Research in Toxicology. 17: 1297-1297. DOI: 10.1021/Tx049788F  0.745
2003 Hagrman D, Goodisman J, Dabrowiak JC, Souid AK. Kinetic study on the reaction of cisplatin with metallothionein. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 916-23. PMID 12814969 DOI: 10.1124/Dmd.31.7.916  0.324
2002 Dabrowiak JC, Goodisman J, Souid AK. Kinetic study of the reaction of cisplatin with thiols. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 1378-84. PMID 12433807 DOI: 10.1124/Dmd.30.12.1378  0.318
2002 McPike MP, Goodisman J, Dabrowiak JC. Footprinting and circular dichroism studies on paromomycin binding to the packaging region of human immunodeficiency virus type-1. Bioorganic & Medicinal Chemistry. 10: 3663-72. PMID 12213482 DOI: 10.1016/S0968-0896(02)00220-1  0.788
2002 Tacka KA, Dabrowiak JC, Goodisman J, Souid AK. Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 875-82. PMID 12124304 DOI: 10.1124/Dmd.30.8.875  0.77
2002 McPike MP, Sullivan JM, Goodisman J, Dabrowiak JC. Footprinting, circular dichroism and UV melting studies on neomycin B binding to the packaging region of human immunodeficiency virus type-1 RNA. Nucleic Acids Research. 30: 2825-31. PMID 12087166 DOI: 10.1093/Nar/Gkf402  0.779
2002 Sullivan JM, Goodisman J, Dabrowiak JC. Absorption studies on aminoglycoside binding to the packaging region of human immunodeficiency virus type-1. Bioorganic & Medicinal Chemistry Letters. 12: 615-8. PMID 11844684 DOI: 10.1016/S0960-894X(01)00823-X  0.363
2002 Sadowitz PD, Hubbard BA, Dabrowiak JC, Goodisman J, Tacka KA, Aktas MK, Cunningham MJ, Dubowy RL, Souid AK. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 183-90. PMID 11792689 DOI: 10.1124/Dmd.30.2.183  0.804
2001 McPike MP, Goodisman J, Dabrowiak JC. Drug-RNA footprinting. Methods in Enzymology. 340: 431-49. PMID 11494862 DOI: 10.1016/S0076-6879(01)40435-6  0.779
2000 Shubsda MF, Kirk CA, Goodisman J, Dabrowiak JC. Binding of human immunodeficiency virus type 1 nucleocapsid protein to psi-RNA-SL3. Biophysical Chemistry. 87: 149-65. PMID 11099178 DOI: 10.1016/S0301-4622(00)00188-5  0.769
2000 Dabrowiak JC, Hatala PJ, McPike MP. A Molecular Modeling Program for Teaching Structural Biochemistry Journal of Chemical Education. 77: 397-400. DOI: 10.1021/Ed077P397  0.741
1999 Shubsda M, Goodisman J, Dabrowiak JC. Characterization of hairpin-duplex interconversion of DNA using polyacrylamide gel electrophoresis. Biophysical Chemistry. 76: 95-115. PMID 11396505 DOI: 10.1016/S0301-4622(98)00217-8  0.788
1999 Shubsda MF, McPike MP, Goodisman J, Dabrowiak JC. Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1. Biochemistry. 38: 10147-57. PMID 10433723 DOI: 10.1021/Bi990744T  0.758
1997 Goodisman J, Kirk C, Dabrowiak JC. Kinetic analysis of drug cleavage of closed-circular DNA. Biophysical Chemistry. 69: 249-68. PMID 9474758 DOI: 10.1016/S0301-4622(97)00098-7  0.386
1997 Dabrowiak JC, Goodisman J, Ward B. Quantitative DNA footprinting. Methods in Molecular Biology (Clifton, N.J.). 90: 23-42. PMID 9407525 DOI: 10.1385/0-89603-447-X:23  0.344
1997 Kirk CA, Goodisman J, Beerman TA, Gawron LS, Dabrowiak JC. Kinetics of cleavage of intra- and extracellular simian virus 40 DNA with the enediyne anticancer drug C-1027. Biophysical Chemistry. 63: 201-9. PMID 9108692 DOI: 10.1016/S0301-4622(96)02217-X  0.682
1997 Shubsda MF, Goodisman J, Dabrowiak JC. Quantitation of ethidium-stained closed circular DNA in agarose gels. Journal of Biochemical and Biophysical Methods. 34: 73-9. PMID 9089386 DOI: 10.1016/S0165-022X(96)01204-3  0.777
1996 Hiort C, Goodisman J, Dabrowiak JC. Cleavage of DNA by the insulin-mimetic compound, NH4[VO(O2)2(phen)]. Biochemistry. 35: 12354-62. PMID 8823170 DOI: 10.1021/Bi9606253  0.397
1995 Hiort C, Goodisman J, Dabrowiak JC. Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex. Molecular and Cellular Biochemistry. 153: 31-6. PMID 8927045 DOI: 10.1007/Bf01075916  0.358
1994 Sehlstedt U, Kim SK, Carter P, Goodisman J, Vollano JF, Nordén B, Dabrowiak JC. Interaction of cationic porphyrins with DNA. Biochemistry. 33: 417-26. PMID 8286372 DOI: 10.1021/Bi00168A005  0.381
1994 Shubsda M, Kishikawa H, Goodisman J, Dabrowiak J. Quantitative footprinting analysis. Journal of Molecular Recognition : Jmr. 7: 133-9. PMID 7826673 DOI: 10.1002/Jmr.300070210  0.793
1994 Falzon L, Kirk C, Chaires JB, Dabrowiak JC. PCR generation of large amounts of purified DNA Journal of Biochemical and Biophysical Methods. 29: 251-257. PMID 7699202 DOI: 10.1016/0165-022X(94)90036-1  0.405
1992 Goodisman J, Dabrowiak JC. Structural changes and enhancements in DNase I footprinting experiments. Biochemistry. 31: 1058-64. PMID 1734955 DOI: 10.1021/Bi00119A014  0.354
1992 Goodisman J, Rehfuss R, Ward B, Dabrowiak JC. Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry. 31: 1046-58. PMID 1734954 DOI: 10.1021/Bi00119A013  0.403
1992 Satyanarayana S, Dabrowiak JC, Chaires JB. Neither delta- nor lambda-tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation. Biochemistry. 31: 9319-24. PMID 1390718 DOI: 10.1021/Bi00154A001  0.41
1992 Stankus A, Goodisman J, Dabrowiak JC. Quantitative footprinting analysis of the chromomycin A3--DNA interaction. Biochemistry. 31: 9310-8. PMID 1390717 DOI: 10.1021/Bi00153A026  0.42
1991 Kishikawa H, Jiang YP, Goodisman J, Dabrowiak JC. Coupled kinetic analysis of cleavage of DNA by esperamicin and calicheamicin Journal of the American Chemical Society. 113: 5434-5440. DOI: 10.1021/Ja00014A040  0.415
1990 Rehfuss R, Goodisman J, Dabrowiak JC. Quantitative footprinting analysis. Binding to a single site. Biochemistry. 29: 777-81. PMID 2337596 DOI: 10.1021/Bi00455A027  0.373
1990 Dabrowiak JC, Goodisman J, Kissinger K. Thermodynamic data from drug-DNA footprinting experiments. Biochemistry. 29: 6139-45. PMID 2169863 DOI: 10.1021/Bi00478A005  0.413
1990 Kissinger KL, Dabrowiak JC, Lown JW. Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis netropsin analogues deduced from footprinting analysis Chemical Research in Toxicology. 3: 162-168. PMID 1966670 DOI: 10.1021/Tx00014A013  0.388
1989 Long BH, Golik J, Forenza S, Ward B, Rehfuss R, Dabrowiak JC, Catino JJ, Musial ST, Brookshire KW, Doyle TW. Esperamicins, a class of potent antitumor antibiotics: mechanism of action. Proceedings of the National Academy of Sciences of the United States of America. 86: 2-6. PMID 2643098 DOI: 10.1073/Pnas.86.1.2  0.399
1989 Lee M, Shea RG, Hartley JA, Lown JW, Kissinger K, Dabrowiak JC, Vesnaver G, Breslauer KJ, Pon RT. Molecular recognition between oligopeptides and nucleic acids. Sequence specific binding of (4S)-(+)- and (4R)-(-)-dihydrokikumycin B to DNA deduced from 1H NMR, footprinting studies and thermodynamic data. Journal of Molecular Recognition : Jmr. 2: 6-17. PMID 2636895 DOI: 10.1002/Jmr.300020103  0.363
1989 Dabrowiak JC, Kissinger K, Goodisman J. Quantitative footprinting analysis of drug-DNA interactions: Fe(III) methidium-propyl-EDTA as a probe. Electrophoresis. 10: 404-12. PMID 2548840 DOI: 10.1002/Elps.1150100519  0.393
1989 Dabrowiak JC, Ward B, Goodisman J. Quantitative footprinting analysis using a DNA-cleaving metalloporphyrin complex. Biochemistry. 28: 3314-22. PMID 2545255 DOI: 10.1021/Bi00434A029  0.43
1988 Ward B, Rehfuss R, Goodisman J, Dabrowiak JC. Determination of netropsin-DNA binding constants from footprinting data. Biochemistry. 27: 1198-205. PMID 2835086 DOI: 10.1021/Bi00404A020  0.424
1988 Ward B, Rehfuss R, Goodisman J, Dabrowiak JC. Rate enhancements in the DNase I footprinting experiment. Nucleic Acids Research. 16: 1359-69. PMID 2831498 DOI: 10.1093/Nar/16.4.1359  0.401
1988 Raner G, Ward B, Dabrowiak JC. Interaction of cationic manganese porphyrins with DNA. a binding model Journal of Coordination Chemistry. 19: 17-23. DOI: 10.1080/00958972.1988.9728140  0.378
1987 Dabrowiak JC, Bradner WT. 4 Platinum Antitumour Agents Progress in Medicinal Chemistry. 24: 129-158. PMID 3332917 DOI: 10.1016/S0079-6468(08)70421-1  0.305
1987 Ward B, Rehfuss R, Dabrowiak JC. Quantitative footprinting analysis of the netropsin-dna interaction Journal of Biomolecular Structure and Dynamics. 4: 685-695. PMID 2855921 DOI: 10.1080/07391102.1987.10507672  0.43
1987 Kissinger K, Krowicki K, Dabrowiak JC, Lown JW. Molecular recognition between oligopeptides and nucleic acids. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding Biochemistry. 26: 5590-5595. PMID 2823885 DOI: 10.1021/Bi00392A002  0.348
1987 Ward B, Dabrowiak JC. DNA binding specificity of the gold(III) complex (C2H5)3PAuBr3 Journal of the American Chemical Society. 109: 3810-3811. DOI: 10.1021/Ja00246A065  0.357
1986 Ward B, Skorobogaty A, Dabrowiak JC. DNA cleavage specificity of a group of cationic metalloporphyrins Biochemistry®. 25: 6875-6883. PMID 3801399 DOI: 10.1021/Bi00370A021  0.392
1986 Bromley SD, Ward BW, Dabrowiak JC. Cationic porphyrins as probes of DNA structure Nucleic Acids Research. 14: 9133-9148. PMID 3786148 DOI: 10.1093/Nar/14.22.9133  0.383
1986 Ward B, Skorobogaty A, Dabrowiak JC. DNA binding specificity of a series of cationic metalloporphyrin complexes Biochemistry. 25: 7827-7833. PMID 3026462 DOI: 10.1021/Bi00372A007  0.415
1986 Lown JW, Krowicki K, Bhat UG, Skorobogaty A, Ward B, Dabrowiak JC. Molecular recognition between oligopeptides and nucleic acids: Novel imidazole-containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity Biochemistry. 25: 7408-7416. PMID 3026455 DOI: 10.1021/Bi00371A024  0.412
1986 Meinema HA, Verbeek F, Marsman JW, Bulten EJ, Dabrowiak JC, Krishnan BS, Spek AL. The synthesis and characterization of 1,1-bis(aminomethyl)cyclohexaneplatinum(II) compounds and the crystal structure determination of 1,1-bis(aminomethyl)-cyclohexaneaquosulphatoplatinum(II) monohydrate Inorganica Chimica Acta. 114: 127-135. DOI: 10.1016/S0020-1693(00)86443-9  0.302
1985 Goodisman J, Dabrowiak JC. Theoretical analysis of the footprinting experiment. Journal of Biomolecular Structure & Dynamics. 2: 967-79. PMID 2855783 DOI: 10.1080/07391102.1985.10507613  0.352
1984 Blank CE, Dabrowiak JC. Absorption and circular dichroism studies of a gold (I)-DNA complex. Journal of Inorganic Biochemistry. 21: 21-9. PMID 6547163 DOI: 10.1016/0162-0134(84)85036-9  0.395
1984 Brandon RJ, Dabrowiak JC. Synthesis, characterization, and properties of a group of platinum(IV) complexes Journal of Medicinal Chemistry. 27: 861-865. PMID 6330359 DOI: 10.1002/Chin.198448306  0.328
1983 Lane MJ, Dabrowiak JC, Vournakis JN. Sequence specificity of actinomycin D and Netropsin binding to pBR322 DNA analyzed by protection from DNase I Proceedings of the National Academy of Sciences of the United States of America. 80: 3260-3264. PMID 6304702 DOI: 10.1073/Pnas.80.11.3260  0.396
1983 Dabrowiak JC. Sequence specificity of drug-DNA interactions Life Sciences. 32: 2915-2931. PMID 6191168 DOI: 10.1016/0024-3205(83)90642-2  0.397
1982 Spinelli M, Dabrowiak JC. Interaction of copper(II) ions with the daunomycin-calf thymus deoxyribonucleic acid complex Biochemistry. 21: 5862-5870. PMID 7150531 DOI: 10.1021/Bi00266A021  0.357
1982 Greenaway FT, Dabrowiak JC. The binding of copper ions to daunomycin and adriamycin Journal of Inorganic Biochemistry. 16: 91-107. DOI: 10.1016/S0162-0134(00)80218-4  0.326
1981 Dabrowiak JC, Tsukayama M. Cobalt(III) complex of pseudotetrapeptide A of bleomycin Journal of the American Chemical Society. 103: 7543-7550. DOI: 10.1002/Chin.198212323  0.305
1980 Greenaway FT, Brown LM, Dabrowiak JC, Thompson MR, Day VM. Copper(II) complexes of the antiulcer drug cimetidine [6] Journal of the American Chemical Society. 102: 7782-7784. DOI: 10.1021/Ja00546A027  0.305
1980 Dabrowiak JC. The coordination chemistry of bleomycin: a review Journal of Inorganic Biochemistry. 13: 317-337. DOI: 10.1016/S0162-0134(00)80252-4  0.33
1978 Dabrowiak JC. Transition-metal binding site of bleomycin A2 A carbon-13 nuclear magnetic resonance study of the zinc(II) and copper(II) derivatives Biochemistry. 17: 4090-4096. PMID 81685 DOI: 10.1021/Bi00612A034  0.332
1975 Dabrowiak JC, Busch DH. Iron complexes with macrocyclic ligands containing the .alpha.-diimine functional unit and its position-specific formation under the influence of the iron atom Inorganic Chemistry. 14: 1881-1888. DOI: 10.1021/Ic50150A031  0.526
1975 Bryan PS, Dabrowiak JC. Synthesis and characterization of manganese complexes containing a synthetic macrocyclic ligand Inorganic Chemistry. 14: 296-299. DOI: 10.1002/Chin.197516388  0.303
1975 Dabrowiak JC, Busch DH. Iron complexes with macrocyclic ligands containing the α-diimine functional unit and its position-specific formation under the influence of the iron atom Inorganic Chemistry. 14: 1881-1888.  0.517
1972 Gore ES, Dabrowiak JC, Busch DH. Transmission of electronic effects in cobalt(III) complexes of macrocyclic ligands: 1H nuclear magnetic resonance study Journal of the Chemical Society, Chemical Communications. 923-924. DOI: 10.1039/C39720000923  0.549
1972 Dabrowiak JC, Lovecchio FV, Goedken VL, Busch DH. Synthesis and electrochemical behavior of a new series of macrocyclic complexes of iron produced by oxidative dehydrogenation and tautomerization [5] Journal of the American Chemical Society. 94: 5502-5504. DOI: 10.1021/Ja00770A059  0.557
1972 Dabrowiak JC, Merrell PH, Busch DH. High- and low-spin six-coordinate complexes of iron(II) with a saturated tetradentate macrocyclic ligand Inorganic Chemistry. 11: 1979-1988. DOI: 10.1021/Ic50115A001  0.547
1972 DABROWIAK JC, MERRELL PH, BUSCH DH. ChemInform Abstract: SECHSFACH-KOORDINIERTE HIGH- UND LOW-SPIN-KOMPLEXE VON EISEN(II) MIT EINEM GESAETTIGTEN VIERZAEHNIGEN MAKROCYCLISCHEN LIGANDEN Chemischer Informationsdienst. 3. DOI: 10.1002/Chin.197246346  0.513
1972 DABROWIAK JC, LEVECCHIO FV, GOEDKEN VL, BUSCH DH. ChemInform Abstract: SYNTH. UND ELEKTROCHEMISCHES VERH. EINER NEUEN SERIE VON DURCH OXIDATIVE DEHYDROGENIERUNG UND TAUTOMERISIERUNG HERGESTELLTEN MAKROCYCLISCHEN EISENKOMPLEXEN Chemischer Informationsdienst. 3: no-no. DOI: 10.1002/Chin.197242419  0.652
1971 Dabrowiak JC, Cooke DW. Gas-liquid chromatography of the optical isomers of threonine and allothreonine. Analytical Chemistry. 43: 791-3. PMID 5122635  0.578
Show low-probability matches.